Recent paradigm shifts in molecular cardiac imaging—Establishing precision cardiology through novel 18 F-labeled PET radiotracers

Rudolf A. Werner, Xinyu Chen, Steven P. Rowe, Constantin Lapa, Mehrbod S. Javadi, Takahiro Higuchi

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

In nuclear cardiology, numerous single-photon emission computed tomography radiotracers have been advocated to reflect various cardiac metabolic and functional conditions, but positron emission tomography (PET) may offer a more thorough evaluation, mainly due to superior characteristics associated with the latter imaging modality. This shift in recent years has been fueled by the introduction of 18 F-labeled PET radiotracers. Due to physical and chemical key properties, these imaging agents allow for more flexibility of imaging protocols and a better employment in the clinic. Potentially rendering perfusion, viability, innervation and inflammation, 18 F-labeled PET radiotracers may truly pave the way for a global assessment of the current metabolic and functional status of the heart, e.g. after acute myocardial infarction or for progressed heart failure. The present review aims to provide a precise overview of those recently introduced 18 F-labeled cardiac imaging agents and how those state-of-the-art, top-tier radiotracers may redefine precision medicine in cardiology.

Original languageEnglish
JournalTrends in Cardiovascular Medicine
DOIs
Publication statusAccepted/In press - Jan 1 2019

Fingerprint

Cardiology
Positron-Emission Tomography
Precision Medicine
Single-Photon Emission-Computed Tomography
Heart Failure
Perfusion
Myocardial Infarction
Inflammation

Keywords

  • F
  • Heart failure
  • Inflammation
  • Innervation
  • MPI
  • Myocardial infarction
  • Myocardial perfusion imaging
  • PET
  • Positron emission tomography
  • Single-photon emission computed tomography
  • SPECT
  • Viability

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Recent paradigm shifts in molecular cardiac imaging—Establishing precision cardiology through novel 18 F-labeled PET radiotracers . / Werner, Rudolf A.; Chen, Xinyu; Rowe, Steven P.; Lapa, Constantin; Javadi, Mehrbod S.; Higuchi, Takahiro.

In: Trends in Cardiovascular Medicine, 01.01.2019.

Research output: Contribution to journalReview article

@article{46d24f6d945c45fc8865e359ff9b84c9,
title = "Recent paradigm shifts in molecular cardiac imaging—Establishing precision cardiology through novel 18 F-labeled PET radiotracers",
abstract = "In nuclear cardiology, numerous single-photon emission computed tomography radiotracers have been advocated to reflect various cardiac metabolic and functional conditions, but positron emission tomography (PET) may offer a more thorough evaluation, mainly due to superior characteristics associated with the latter imaging modality. This shift in recent years has been fueled by the introduction of 18 F-labeled PET radiotracers. Due to physical and chemical key properties, these imaging agents allow for more flexibility of imaging protocols and a better employment in the clinic. Potentially rendering perfusion, viability, innervation and inflammation, 18 F-labeled PET radiotracers may truly pave the way for a global assessment of the current metabolic and functional status of the heart, e.g. after acute myocardial infarction or for progressed heart failure. The present review aims to provide a precise overview of those recently introduced 18 F-labeled cardiac imaging agents and how those state-of-the-art, top-tier radiotracers may redefine precision medicine in cardiology.",
keywords = "F, Heart failure, Inflammation, Innervation, MPI, Myocardial infarction, Myocardial perfusion imaging, PET, Positron emission tomography, Single-photon emission computed tomography, SPECT, Viability",
author = "Werner, {Rudolf A.} and Xinyu Chen and Rowe, {Steven P.} and Constantin Lapa and Javadi, {Mehrbod S.} and Takahiro Higuchi",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.tcm.2019.02.007",
language = "English",
journal = "Trends in Cardiovascular Medicine",
issn = "1050-1738",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Recent paradigm shifts in molecular cardiac imaging—Establishing precision cardiology through novel 18 F-labeled PET radiotracers

AU - Werner, Rudolf A.

AU - Chen, Xinyu

AU - Rowe, Steven P.

AU - Lapa, Constantin

AU - Javadi, Mehrbod S.

AU - Higuchi, Takahiro

PY - 2019/1/1

Y1 - 2019/1/1

N2 - In nuclear cardiology, numerous single-photon emission computed tomography radiotracers have been advocated to reflect various cardiac metabolic and functional conditions, but positron emission tomography (PET) may offer a more thorough evaluation, mainly due to superior characteristics associated with the latter imaging modality. This shift in recent years has been fueled by the introduction of 18 F-labeled PET radiotracers. Due to physical and chemical key properties, these imaging agents allow for more flexibility of imaging protocols and a better employment in the clinic. Potentially rendering perfusion, viability, innervation and inflammation, 18 F-labeled PET radiotracers may truly pave the way for a global assessment of the current metabolic and functional status of the heart, e.g. after acute myocardial infarction or for progressed heart failure. The present review aims to provide a precise overview of those recently introduced 18 F-labeled cardiac imaging agents and how those state-of-the-art, top-tier radiotracers may redefine precision medicine in cardiology.

AB - In nuclear cardiology, numerous single-photon emission computed tomography radiotracers have been advocated to reflect various cardiac metabolic and functional conditions, but positron emission tomography (PET) may offer a more thorough evaluation, mainly due to superior characteristics associated with the latter imaging modality. This shift in recent years has been fueled by the introduction of 18 F-labeled PET radiotracers. Due to physical and chemical key properties, these imaging agents allow for more flexibility of imaging protocols and a better employment in the clinic. Potentially rendering perfusion, viability, innervation and inflammation, 18 F-labeled PET radiotracers may truly pave the way for a global assessment of the current metabolic and functional status of the heart, e.g. after acute myocardial infarction or for progressed heart failure. The present review aims to provide a precise overview of those recently introduced 18 F-labeled cardiac imaging agents and how those state-of-the-art, top-tier radiotracers may redefine precision medicine in cardiology.

KW - F

KW - Heart failure

KW - Inflammation

KW - Innervation

KW - MPI

KW - Myocardial infarction

KW - Myocardial perfusion imaging

KW - PET

KW - Positron emission tomography

KW - Single-photon emission computed tomography

KW - SPECT

KW - Viability

UR - http://www.scopus.com/inward/record.url?scp=85062019436&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062019436&partnerID=8YFLogxK

U2 - 10.1016/j.tcm.2019.02.007

DO - 10.1016/j.tcm.2019.02.007

M3 - Review article

AN - SCOPUS:85062019436

JO - Trends in Cardiovascular Medicine

JF - Trends in Cardiovascular Medicine

SN - 1050-1738

ER -